T
BTAL icon

Transce3nd’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Transce3nd’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-203
Closed -$3.59K – 288
2025
Q2 		$3.59K Hold
203
– – ﹤0.01% 799
2025
Q1 		$4.23K Hold
203
– – ﹤0.01% 753
2024
Q4 		$3.75K Buy
+203
New +$3.9K ﹤0.01% 985

Other funds holding BTAL

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
WIA
Wealthedge Investment Advisors New York $272M AUM 10.26% 1-Year Est. Return
CCMG
Clark Capital Management Group Philadelphia, Pennsylvania $16.2B AUM 29.8% 1-Year Est. Return

Transce3nd's BTAL Position: Q3 2025 in Review

Transce3nd sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2025, closing a stake of 203 shares — an estimated $3.59K sold.

Transce3nd first reported a position in BTAL in Q4 2024 and held it in 3 quarters. The position peaked at $4.23K in Q1 2025. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2025.

  • Transce3nd reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2025 after selling out during the quarter.
  • Transce3nd sold 203 AGF US Market Neutral Anti-Beta Fund shares in Q3 2025, an estimated $3.59K.
  • Transce3nd first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and held it in 3 quarters.
  • Transce3nd's AGF US Market Neutral Anti-Beta Fund position peaked at $4.23K in Q1 2025.
  • 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.